Stefano Fiorucci

Person

Perugia, IT

People

Patents Grantslast 30 patents

Information Patent Grant
Isoxazole as FXR receptor agonists
- Patent number 11,332,450
- Issue date May 17, 2022
- Bar Pharmaceuticals Societa' A Responsabilita' Limitata
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cholane derivatives for use in the treatment and/or prevention of F...
- Patent number 11,117,926
- Issue date Sep 14, 2021
- BAR PHARMACEUTICALS S.R.L.
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 10,987,362
- Issue date Apr 27, 2021
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cholane derivatives for use in the treatment and/or prevention of F...
- Patent number 10,407,462
- Issue date Sep 10, 2019
- BAR PHARMACEUTICALS S.R.L.
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 10,258,633
- Issue date Apr 16, 2019
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 9,763,964
- Issue date Sep 19, 2017
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of fibrosis using FXR ligands
- Patent number 9,498,484
- Issue date Nov 22, 2016
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 9,090,652
- Issue date Jul 28, 2015
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 8,546,365
- Issue date Oct 1, 2013
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of 4- or 5-aminosalicylic acid
- Patent number 8,114,857
- Issue date Feb 14, 2012
- Antibe Therapeutics Inc.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 4- or 5-aminosalicylic acid
- Patent number 8,114,858
- Issue date Feb 14, 2012
- Antibe Therapeutics Inc.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 7,932,244
- Issue date Apr 26, 2011
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Derivatives of 4- or 5-aminosalicylic acid
- Patent number 7,910,568
- Issue date Mar 22, 2011
- Antibe Therapeutics Inc.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 4- or 5-aminosalicylic acid
- Patent number 7,879,827
- Issue date Feb 1, 2011
- Antibe Therapeutics Inc.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Patent number 7,858,608
- Issue date Dec 28, 2010
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Derivatives of 4- or 5-aminosalicylic acid
- Patent number 7,498,355
- Issue date Mar 3, 2009
- Antibe Therapeutics Inc.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
6-SUBSTITUTED, 22-CYANO HYODEOXYCHOLANIC ANALOGUES AND USES THEREOF
- Publication number 20230066156
- Publication date Mar 2, 2023
- PRECISION BIO-THERAPEUTICS S.R.L.
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE...
- Publication number 20220160794
- Publication date May 26, 2022
- ORMENDES SA
- Stefano FIORUCCI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20210346400
- Publication date Nov 11, 2021
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoxazole as FXR Receptor Agonists
- Publication number 20210269409
- Publication date Sep 2, 2021
- Bar Pharmaceuticals Societa' A Responsabilita' Limitata
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20200397803
- Publication date Dec 24, 2020
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20200197414
- Publication date Jun 25, 2020
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF F...
- Publication number 20190352328
- Publication date Nov 21, 2019
- BAR PHARMACEUTICALS S.R.L.
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF F...
- Publication number 20170190731
- Publication date Jul 6, 2017
- BAR PHARMACEUTICALS S.R.L.
- Angela Zampella
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF FIBROSIS USING FXR LIGANDS
- Publication number 20170165277
- Publication date Jun 15, 2017
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...
- Publication number 20150359805
- Publication date Dec 17, 2015
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...
- Publication number 20140057886
- Publication date Feb 27, 2014
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatmen...
- Publication number 20120283234
- Publication date Nov 8, 2012
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID
- Publication number 20110130368
- Publication date Jun 2, 2011
- ANTIBE THERAPEUTICS INC.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID
- Publication number 20110098257
- Publication date Apr 28, 2011
- ANTIBE THERAPEUTICS INC.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMEN...
- Publication number 20100063018
- Publication date Mar 11, 2010
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID
- Publication number 20090233886
- Publication date Sep 17, 2009
- ANTIBE THERAPEUTICS INC.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Derivaitves of 4-Or 5-Aminosalicylic Acid
- Publication number 20080207564
- Publication date Aug 28, 2008
- ANTIBE THERAPEUTICS INC.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile acid derivatives as FXR ligands for the prevention or treatmen...
- Publication number 20080182832
- Publication date Jul 31, 2008
- Intercept Pharmaceuticals, Inc.
- Roberto Pellicciari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment and prevention of intestinal fibrosis
- Publication number 20080119439
- Publication date May 22, 2008
- Bayer Schering Pharma Aktiengesellschaft
- John Parkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Derivatives of 4- or 5-aminosalicylic acid
- Publication number 20070197479
- Publication date Aug 23, 2007
- ANTIBE THERAPEUTICS INC.
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modulation of MDL-1 activity for treatment of inflammatory disease
- Publication number 20070179094
- Publication date Aug 2, 2007
- BAYER SCHERING PHARMA AG
- Daryl Faulds
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Derivatives of 4- or 5-aminosalicylic acid
- Publication number 20060270635
- Publication date Nov 30, 2006
- John L. Wallace
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of reducing drug-induced adverse side effects in a patient
- Publication number 20060252670
- Publication date Nov 9, 2006
- Intercept Pharmaceuticals Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of fibrosis using FXR ligands
- Publication number 20060069070
- Publication date Mar 30, 2006
- Intercept Pharmaceuticals, Inc.
- Stefano Fiorucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stefano Fiorucci

Person

Patents Grantslast 30 patents

Isoxazole as FXR receptor agonists

Cholane derivatives for use in the treatment and/or prevention of F...

Treatment of fibrosis using FXR ligands

Cholane derivatives for use in the treatment and/or prevention of F...

Treatment of fibrosis using FXR ligands

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Treatment of fibrosis using FXR ligands

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Derivatives of 4- or 5-aminosalicylic acid

Derivatives of 4- or 5-aminosalicylic acid

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Derivatives of 4- or 5-aminosalicylic acid

Derivatives of 4- or 5-aminosalicylic acid

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Derivatives of 4- or 5-aminosalicylic acid

Patents Applicationslast 30 patents

6-SUBSTITUTED, 22-CYANO HYODEOXYCHOLANIC ANALOGUES AND USES THEREOF

USE OF BACILLUS AMYLOLIQUEFACIENS AND/OR BACILLUS SUBTILIS FOR THE...

TREATMENT OF FIBROSIS USING FXR LIGANDS

Isoxazole as FXR Receptor Agonists

TREATMENT OF FIBROSIS USING FXR LIGANDS

TREATMENT OF FIBROSIS USING FXR LIGANDS

CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF F...

CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF F...

TREATMENT OF FIBROSIS USING FXR LIGANDS

Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...

Bile Acid Derivatives as FXR Ligands for the Prevention or Treatmen...

Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatmen...

DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID

DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID

BILE ACID DERIVATIVES AS FXR LIGANDS FOR THE PREVENTION OR TREATMEN...

DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID

Derivaitves of 4-Or 5-Aminosalicylic Acid

Bile acid derivatives as FXR ligands for the prevention or treatmen...

Treatment and prevention of intestinal fibrosis

Derivatives of 4- or 5-aminosalicylic acid

Modulation of MDL-1 activity for treatment of inflammatory disease

Derivatives of 4- or 5-aminosalicylic acid

Method of reducing drug-induced adverse side effects in a patient

Treatment of fibrosis using FXR ligands